Skip to Main Content

Paper Details

Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention.
Clin Cancer Res
6
2022
BRCA1, CDKN2A, ERBB2, GBC, Gallbladder Carcinoma, KRAS, NTRK1, NTRK1 fusions, OncoKB, PIK3CA, RAS, RTK, SMAD4, STK11, TP53, adenocarcinomas, cancer, cancer-associated genes, carcinomas, malignancy, metastatic disease, neuroendocrine, neuroendocrine carcinomas, patients, solid tumor, tumors
Author NameAffiliation
Debyani ChakravartyMarie-Josee & Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Ritika KundraMarie-Josee & Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Nikolaus SchultzMarie-Josee & Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Nikolaus SchultzMarie-Josee & Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Michael F BergerDepartment of Pathology and Laboratory Medicine Memorial Sloan Kettering Cancer Center
Marc LadanyiDepartment of Pathology and Laboratory Medicine Memorial Sloan Kettering Cancer Center
  • 1 - 6

Datasets

Release 1.2